Comparative biomarker profiles of pacritinib, momelotinib, pexidartinib, and ruxolitinib using BioMAP Diversity PLUS panelS. Al-Fayoumi,R. Watson,A. O'Mahony,J.W. SingerEUROPEAN JOURNAL OF CANCER(2016)引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要